M&T Bank
IBB icon

M&T Bank’s iShares Biotechnology ETF IBB Stock Holding History

M&T Bank’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$378K Buy
1,990
+120
+6% +$20.6K ﹤0.01% 1341
2026
Q1 		$316K Hold
1,870
– – ﹤0.01% 1345
2025
Q4 		$316K Hold
1,870
– – ﹤0.01% 1371
2025
Q3 		$270K Sell
1,870
-790
-30% -$108K ﹤0.01% 1256
2025
Q2 		$337K Buy
2,660
+750
+39% +$92.1K ﹤0.01% 1231
2025
Q1 		$244K Sell
1,910
-2,173
-53% -$295K ﹤0.01% 1332
2024
Q4 		$540K Buy
4,083
+172
+4% +$24.2K ﹤0.01% 1135
2024
Q3 		$569K Sell
3,911
-280
-7% -$40.5K ﹤0.01% 1119
2024
Q2 		$575K Sell
4,191
-1,508
-26% -$201K ﹤0.01% 1061
2024
Q1 		$782K Sell
5,699
-1,277
-18% -$174K ﹤0.01% 960
2023
Q4 		$948K Sell
6,976
-1,177
-14% -$144K ﹤0.01% 889
2023
Q3 		$997K Sell
8,153
-2,237
-22% -$284K ﹤0.01% 841
2023
Q2 		$1.32M Sell
10,390
-3,091
-23% -$402K ﹤0.01% 772
2023
Q1 		$1.74M Sell
13,481
-2,308
-15% -$302K 0.01% 674
2022
Q4 		$2.07M Sell
15,789
-5,791
-27% -$748K 0.01% 611
2022
Q3 		$2.52M Sell
21,580
-3,221
-13% -$400K 0.01% 528
2022
Q2 		$1.53M Buy
24,801
+11,394
+85% +$1.35M 0.01% 642
2022
Q1 		$1.75M Buy
13,407
+1,875
+16% +$244K 0.01% 601
2021
Q4 		$1.76M Sell
11,532
-446
-4% -$69.1K 0.01% 604
2021
Q3 		$1.94M Buy
11,978
+55
+0.5% +$9.26K 0.01% 568
2021
Q2 		$1.95M Buy
11,923
+1,015
+9% +$156K 0.01% 575
2021
Q1 		$1.64M Sell
10,908
-4,657
-30% -$740K 0.01% 613
2020
Q4 		$2.36M Buy
15,565
+1,843
+13% +$263K 0.01% 532
2020
Q3 		$1.86M Buy
13,722
+1,692
+14% +$230K 0.01% 549
2020
Q2 		$1.64M Buy
12,030
+1,310
+12% +$167K 0.01% 562
2020
Q1 		$1.16M Buy
+10,720
New +$1.23M 0.01% 647
2019
Q4 		– Sell
-8,938
Closed -$890K – 1511
2019
Q3 		$890K Sell
8,938
-1,458
-14% -$153K ﹤0.01% 762
2019
Q2 		$1.13M Sell
10,396
-29
-0.3% -$3.08K 0.01% 696
2019
Q1 		$1.17M Sell
10,425
-351
-3% -$38.5K 0.01% 673
2018
Q4 		$1.04M Buy
10,776
+458
+4% +$48.6K 0.01% 666
2018
Q3 		$1.26M Sell
10,318
-171
-2% -$20.1K 0.01% 686
2018
Q2 		$1.15M Sell
10,489
-360
-3% -$38.5K 0.01% 717
2018
Q1 		$1.16M Sell
10,849
-1,725
-14% -$191K 0.01% 714
2017
Q4 		$1.34M Sell
12,574
-3,386
-21% -$362K 0.01% 666
2017
Q3 		$1.77M Sell
15,960
-1,011
-6% -$108K 0.01% 566
2017
Q2 		$1.75M Sell
16,971
-2,133
-11% -$210K 0.01% 570
2017
Q1 		$1.87M Buy
19,104
+2,976
+18% +$285K 0.01% 552
2016
Q4 		$1.43M Buy
16,128
+957
+6% +$87.1K 0.01% 656
2016
Q3 		$1.46M Buy
15,171
+396
+3% +$37.7K 0.01% 644
2016
Q2 		$1.27M Buy
14,775
+612
+4% +$54.9K 0.01% 696
2016
Q1 		$1.23M Sell
14,163
-885
-6% -$79.1K 0.01% 705
2015
Q4 		$1.7M Sell
15,048
-372
-2% -$40.4K 0.01% 619
2015
Q3 		$1.56M Sell
15,420
-2,388
-13% -$286K 0.01% 648
2015
Q2 		$2.19M Sell
17,808
-1,614
-8% -$193K 0.01% 608
2015
Q1 		$2.22M Sell
19,422
-2,226
-10% -$246K 0.01% 588
2014
Q4 		$2.19M Buy
21,648
+2,184
+11% +$212K 0.01% 579
2014
Q3 		$1.78M Buy
+19,464
New +$1.71M 0.01% 653

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

M&T Bank's IBB Position: Q2 2026 in Review

M&T Bank increased its iShares Biotechnology ETF (IBB) stake by 6.4% in Q2 2026, buying an estimated $20.6K and bringing the position to 1,990 shares worth $378K. The position accounts for ﹤0.01% of the portfolio, ranked #1341.

M&T Bank first reported a position in IBB in Q3 2014 and has held it in 47 quarters since. The position peaked at $2.52M in Q3 2022. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • M&T Bank held 1,990 shares of iShares Biotechnology ETF worth $378K as of Q2 2026.
  • M&T Bank bought 120 iShares Biotechnology ETF shares in Q2 2026, an estimated $20.6K.
  • iShares Biotechnology ETF made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1341 holding.
  • M&T Bank first reported a position in iShares Biotechnology ETF in Q3 2014 and has held it in 47 quarters since.
  • M&T Bank's iShares Biotechnology ETF position peaked at $2.52M in Q3 2022.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.